Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study

Table 4 ApoCIII concentration in chylomicron-free serum fasting and postprandial stratified by metabolic syndrome and diabetes-related traits

ApoCIII concentrations in metabolic syndrome and diabetes		Fasting		Postprandial
ApoCIII concentrations in metabolic syndrome and diabetes		ApoCIII	P value	ApoCIII	P value
Metabolic syndrome	yes	8.2 (4.7)	0.003	7.9 (4.8)	0.026
Metabolic syndrome	no	6.4 (2.7)	0.003	6.5 (3.0)	0.026
IFG, IGT, Diabetes	yes	8.0 (4.4)	0.013	7.7 (4.5)	0.038
IFG, IGT, Diabetes	no	6.3 (3.1)	0.013	6.3 (3.2)	0.038

Values for apoCIII are in mg/dL and presented as mean (standard deviation). IFG impaired fasting glucose, IGT impaired glucose tolerance

ISSN: 1476-511X